Tech & Science
Data demonstrates halting of disease progression in patients with ALS at 24 weeks.
Hi, what are you looking for?
Data demonstrates halting of disease progression in patients with ALS at 24 weeks.
According to the Center for Disease Control and Prevention, 376,000 cases of reported Lyme disease occur in the U.S. Lyme disease is a bacterial...
Amyotrophic lateral sclerosis commonly referred to as ALS, motor neurone disease, or to Lou Gehrig’s disease. The disease is rare and it acts to...
California-based biotechnology company Genervon has announced results of a Phase 2 clinical trial involving 12 amyotrophic lateral sclerosis (ALS) patients. The experimental drug, called...